Influenza-B Tokio Protein

Biorbyt

Influenza-B Tokio Protein

16

Inactivation: Thimerosal and beta propiolactone treatmentThis product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. Immunological Activity: Serological studies of influenza B virus, immunogen for antibody production.Tested with anti-influenza B monoclonal antibodies in ELISA

Research Use Only

90.0%

Influenza-B Tokio protein

12352202